February 27, 2017
Allergan’s IR vice president leaves
Allergan’s Vice President of Investor Relations, Lisa DeFrancesco, has resign after being nearly 8 years of leading the Investor Relations of the company.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Allergan
February 13, 2017
Allergan buys medical aesthetics specialist Zeltiq for $2.475 billion
Allergan has made another acquisition deal in expanding its medical aesthetics portfolio by buying Zeltiq Aesthetics for $2.475 billion.
February 8, 2017
Allergan’s revenue up, plans launching nine products this year
Allergan’s net revenue for the fourth quarter 2016 rose 7 percent to $3.86 billion, mostly driven by better sales of Botox, Linzess and certain other new products.
February 7, 2017
Allergan hears NASEM’s call for fighting preventable blindness in USA
Allergan said on Tuesday it wants to commit to working on preventable blindness in the USA.
February 3, 2017
Allergan expects annual dividend rise
Allergan’s boss Brent Saunders said that the company plans to increase dividend on an annual basis over time.
February 1, 2017
Allergan completes $2.9 LifeCell buy, boosts up its plastic surgery business
Allergan has completed the $2.9 billion purchase of Acelity’s subsidiary LifeCell, adding commercial products to its regenerative medicine portfolio, and LifeCell’s innovative manufacturing capabilities and its R&D operations, based in New Jersey.
January 30, 2017
Allergan’s to update label on its antibiotic Avycaz
Allergan has ensured permit to update the label for its Avycaz with new data from two third phase clinical trials, about treatining patients with certain complicated urinary tract infections (UTI).
January 26, 2017
FDA OK’s Ironwood/Allergan’s constipation drug
Ironwood Pharmaceuticals and Allergan have won U.S. Food and Drug Administration’s (FDA) approval for 72 mcg dose of Linzess (linaclotide) for the treatment of chronic idiopathic constipation (CIC) in adult patients.
January 19, 2017
FDA approves Allergan’s skin disease drug
U.S. Food and Drug Administration (FDA) has approved Allergan’s Rhofade skin desease cream, a topical treatment of persistent facial erythema (redness)…
January 17, 2017
Allergan, Gedeon Richter report positive results from uterine fibroids drug trial
Allergan and Gedeon Richter have reported positive results from Venus II, the second of two pivotal phase III clinical trials…